A previous study found that systemic hyperinsulinemia due to hyperglycemia caused by PI3K inhibitors would make these agents ineffective, and that administration of ketogenic diets to suppress insulin feedback enhances the efficacy of PI3K inhibitors in mouse model [23]. The gene discussed is PIK3CA; the disease is Hyperglycemia.